European Case Law Identifier: | ECLI:EP:BA:2003:T004300.20030509 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 09 May 2003 | ||||||||
Case number: | T 0043/00 | ||||||||
Application number: | 92103963.2 | ||||||||
IPC class: | A61K 9/20 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Low dose dry pharmaceutical preparations | ||||||||
Applicant name: | Akzo Nobel N.V. | ||||||||
Opponent name: | Jenapharm GmbH & Co. KG Meggle GmbH Schering AG |
||||||||
Board: | 3.3.02 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Main request: novelty (no) - prior use adequately substantiated by evidence: prejudicial to the novelty of claim 5 as granted First and second auxiliary requests: admissible and allowable Remittal to the first instance for further prosecution: prior use represents highly relevant state of the art not considered by the first instance - case different from that on which the first instance's decision was based |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t000043eu1.html
Date retrieved: 17 May 2021